{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:38:50Z","timestamp":1787027930651,"version":"build-2736575974"},"reference-count":33,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation","award":["075-15-2022-301"],"award-info":[{"award-number":["075-15-2022-301"]}]},{"name":"Ministry of Science and Higher Education of the Russian Federation","award":["075-15-2022-301"],"award-info":[{"award-number":["075-15-2022-301"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Recent studies have demonstrated the relationship between vitamin D deficiency, infection severity and mortality from COVID-19. This study aimed to analyze the vitamin D metabolites and cytokine expression levels of COVID-19 patients who were hospitalized with bolus cholecalciferol supplementation. Materials and methods: This study represents the next stage of the open-label randomized pilot conducted by the Almazov National Medical Research Centre. A total of 44 hospitalized patients, comparable in demographic, clinical, laboratory and instrumental baseline characteristics, with moderate\/severe COVID-19 were included. All patients had similar doses of concomitant corticosteroid therapy. Twenty-two patients received 50,000 IU cholecalciferol on the first and eighth days of hospitalization. The serum 25(OH)D, 1,25(OH)2D and 28 plasma cytokines were estimated for each group initially and on the ninth day of hospitalization. Results: Initially, there were no differences in the 1,25(OH)2D and cytokine levels in patients with vitamin D deficiency and normal 25(OH)D. Bolus cholecalciferol therapy at a total dose of 100,000 IU led to an increase in 25(OH)D levels in hospitalized patients with COVID-19, while the levels of the active metabolite (1,25(OH)2D) did not show significant differences between the groups or in its increased level over time, regardless of cholecalciferol supplementation. Furthermore, cholecalciferol supplementation at a total dose of 100,000 IU did not affect the majority of the cytokines estimated on the ninth day of hospitalization, except for the pro-inflammatory marker IL-1b, the concentration of which was lower in the group of patients without vitamin D supplementation. Conclusions: The 25(OH)D level was positively associated with an anti-inflammatory immune response, but cholecalciferol supplementation at a total dose of 100,000 IU did not affect the active-form vitamin D or cytokine expression levels. This fact may be explained by the impact of corticosteroid therapy, and it requires further investigation in a post-COVID-19 context.<\/jats:p>","DOI":"10.3390\/diagnostics14131408","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T05:08:34Z","timestamp":1719896914000},"page":"1408","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vitamin D Metabolism Parameters and Cytokine Profile in COVID-19 Patients with Bolus Cholecalciferol Supplementation"],"prefix":"10.3390","volume":"14","author":[{"given":"Tatiana L.","family":"Karonova","sequence":"first","affiliation":[{"name":"Almazov National Medical Research Centre, 2, Akkuratov Str., St. Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arina A.","family":"Mikhaylova","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, 2, Akkuratov Str., St. Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ksenia A.","family":"Golovatyuk","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, 2, Akkuratov Str., St. Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4878-6909","authenticated-orcid":false,"given":"Alena T.","family":"Chernikova","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, 2, Akkuratov Str., St. Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoia R.","family":"Korobova","sequence":"additional","affiliation":[{"name":"Saint Petersburg Pasteur Institute, Saint-Petersburg 197101, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia E.","family":"Liubimova","sequence":"additional","affiliation":[{"name":"Saint Petersburg Pasteur Institute, Saint-Petersburg 197101, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-6986","authenticated-orcid":false,"given":"Anna A.","family":"Starshinova","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, 2, Akkuratov Str., St. Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1878-4467","authenticated-orcid":false,"given":"Dmitry A.","family":"Kudlay","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy and Industrial Pharmacy, Faculty of Fundamental Medicine, Lomonosov Moscow State University, Moscow 119991, Russia"},{"name":"Institute of Immunology, Moscow 115478, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4571-8799","authenticated-orcid":false,"given":"Areg A.","family":"Totolian","sequence":"additional","affiliation":[{"name":"Saint Petersburg Pasteur Institute, Saint-Petersburg 197101, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny V.","family":"Shlyakhto","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre, 2, Akkuratov Str., St. Petersburg 197341, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kaufman, H.W., Niles, J.K., Kroll, M.H., Bi, C., and Holick, M.F. (2020). SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0239252"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Karonova, T.L., Golovatyuk, K.A., Aquino, A.D., Kalinina, O.V., Chernikova, A.T., Zaikova, E.K., Lebedev, D.A., Bykova, E.S., and Golovkin, A.S. (2022). Vitamin D Status and Immune Response in Hospitalized Patients with Moderate and Severe COVID-19. Pharmaceuticals, 15.","DOI":"10.3390\/ph15030305"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e2021074","DOI":"10.4178\/epih.e2021074","article-title":"The role of vitamin D deficiency on COVID-19: A systematic review and meta-analysis of observational studies","volume":"43","author":"Kaya","year":"2021","journal-title":"Epidemiol. Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.14341\/probl12820","article-title":"SARS-CoV-2 morbidity depending on vitamin D status","volume":"67","author":"Karonova","year":"2021","journal-title":"Probl. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00210-022-02360-x","article-title":"Hospital and laboratory outcomes of patients with COVID-19 who received vitamin D supplementation: A systematic review and meta-analysis of randomized controlled trials","volume":"396","author":"Zaazouee","year":"2022","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ling, S.F., Broad, E., Murphy, R., Pappachan, J.M., Pardesi-Newton, S., Kong, M.F., and Jude, E.B. (2020). High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study. Nutrients, 12.","DOI":"10.2139\/ssrn.3690902"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Annweiler, G., Corvaisier, M., Gautier, J., Dub\u00e9e, V., Legrand, E., Sacco, G., and Annweiler, C. (2020). Vitamin D Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Quasi-Experimental Study. Nutrients, 12.","DOI":"10.3390\/nu12113377"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kudlay, D., Kofiadi, I., and Khaitov, M. (2022). Peculiarities of the T Cell Immune Response in COVID-19. Vaccines, 10.","DOI":"10.3390\/vaccines10020242"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1172\/JCI88887","article-title":"The vitamin D receptor: Contemporary genomic approaches reveal new basic and translational insights","volume":"127","author":"Pike","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.3390\/nu7043011","article-title":"Vitamin D and 1,25(OH)2D Regulation of T cells","volume":"7","author":"Cantorna","year":"2015","journal-title":"Nutrients"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsbmb.2005.06.002","article-title":"Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts","volume":"97","author":"Mathieu","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3390\/nu5072502","article-title":"Vitamin D and Immune Function","volume":"5","author":"Prietl","year":"2013","journal-title":"Nutrients"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2016.11.004","article-title":"Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro","volume":"137","author":"Telcian","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1182\/blood.V82.4.1300.1300","article-title":"1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages","volume":"82","author":"Kreutz","year":"1993","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Barlow, P.G., Svoboda, P., Mackellar, A., Nash, A.A., York, I.A., Pohl, J., Davidson, D.J., and Donis, R.O. (2011). Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025333"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.21037\/jlpm.2018.11.06","article-title":"Measurement of vitamin D metabolites by mass spectrometry, an analytical challenge","volume":"3","author":"Zelzer","year":"2018","journal-title":"J. Lab. Precis. Med."},{"key":"ref_17","unstructured":"Kozlov, V.A., Tikhonova, E.P., Savchenko, A.A., Kudryavtsev, I.V., Andronova, N.V., Anisimova, E.N., Golovkin, A.S., Demina, D.V., Zdzitovetsky, D.E., and Kalinina, Y.S. (2021). Clinical Immunology\u2014A Practical Guide for Infectious Disease Specialists, Polikor. (In Russian)."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Karonova, T.L., Golovatyuk, K.A., Kudryavtsev, I.V., Chernikova, A.T., Mikhaylova, A.A., Aquino, A.D., Lagutina, D.I., Zaikova, E.K., Kalinina, O.V., and Golovkin, A.S. (2022). Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study. Nutrients, 14.","DOI":"10.3390\/nu14132602"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Kudlay, D., Svistunov, A., and Satyshev, O. (2022). COVID-19 Vaccines: An Updated Overview of Different Platforms. Bioengineering, 9.","DOI":"10.3390\/bioengineering9110714"},{"key":"ref_20","unstructured":"(2023, August 15). Steroid Conversion Calculator. Available online: https:\/\/www.mdcalc.com\/calc\/2040\/steroid-conversion-calculator."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Povaliaeva, A., Bogdanov, V., Pigarova, E., Dzeranova, L., Katamadze, N., Malysheva, N., Ioutsi, V., Nikankina, L., Rozhinskaya, L., and Mokrysheva, N. (2022). Impaired Vitamin D Metabolism in Hospitalized COVID-19 Patients. Pharmaceuticals, 15.","DOI":"10.3390\/ph15080906"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1210\/jc.2011-1600","article-title":"Association of glucocorticoid use and low 25-hydroxyvitamin D levels: Results from the National Health and Nutrition Examination Survey (NHANES): 2001\u20132006","volume":"96","author":"Skversky","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/jcb.22645","article-title":"Novel regulation of 25-hydroxyvitamin D3 24-hydroxylase (24(OH)ase) transcription by glucocorticoids: Cooperative effects of the glucocorticoid receptor, C\/EBP\u03b2, and the Vitamin D receptor in 24(OH)ase transcription","volume":"110","author":"Dhawan","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1677\/joe.0.1640339","article-title":"Regulation of vitamin D-1alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney","volume":"164","author":"Akeno","year":"2000","journal-title":"J. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcn\/46.2.324","article-title":"Calcium and vitamin D supplements: Effects on calcium metabolism in elderly people","volume":"46","author":"Chapuy","year":"1987","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s001980050058","article-title":"Vitamin D and its Major Metabolites: Serum Levels after Graded Oral Dosing in Healthy Men","volume":"8","author":"Heaney","year":"1998","journal-title":"Osteoporos. Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1997S","DOI":"10.3945\/ajcn.2009.27230D","article-title":"Existing and potentially novel functional markers of vitamin D status: A systematic review","volume":"89","author":"Seamans","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Torres, M., Casado, G., Vig\u00f3n, L., Rodr\u00edguez-Mora, S., Mateos, E., Ramos-Mart\u00edn, F., L\u00f3pez-Wolf, D., Sanz-Moreno, J., Ryan-Murua, P., and Taboada-Mart\u00ednez, M.L. (2022). Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D. Biomed Pharmacother., 150.","DOI":"10.1016\/j.biopha.2022.112965"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"120909","DOI":"10.1016\/j.lfs.2022.120909","article-title":"Vitamin D modulates systemic inflammation in patients with severe COVID-19","volume":"307","author":"Hafezi","year":"2022","journal-title":"Life Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/ajcn\/nqab426","article-title":"Effect of a single high dose of vitamin D3 on cytokines, chemokines, and growth factor in patients with moderate to severe COVID-19","volume":"115","author":"Fernandes","year":"2023","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.cell.2021.02.018","article-title":"Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19","volume":"184","author":"Liu","year":"2021","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2036.1996.22164025.x","article-title":"Cytokine modulation by glucocorticoids: Mechanisms and actions in cellular studies","volume":"10","author":"Brattsand","year":"1996","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Beck, I.M., Van Crombruggen, K., Holtappels, G., Daubeuf, F., Frossard, N., Bachert, C., and De Bosscher, K. (2015). Differential cytokine profiles upon comparing selective versus classic glucocorticoid receptor modulation in human peripheral blood mononuclear cells and inferior turbinate tissue. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123068"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/13\/1408\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:08:56Z","timestamp":1760108936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/13\/1408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":33,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["diagnostics14131408"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14131408","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,2]]}}}